Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Hospital Arnau de Vilanova
Valencia, EspañaPublications in collaboration with researchers from Hospital Arnau de Vilanova (14)
2024
-
Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study
Journal of Geriatric Cardiology, Vol. 21, Núm. 7, pp. 723-732
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
2022
-
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program
Medicina Clinica, Vol. 159, Núm. 4, pp. 177-182
-
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947
-
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184
-
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study
European Journal of Clinical Investigation
2021
-
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: Impact of inappropriate doses (the EMIR study)
Journal of Comparative Effectiveness Research, Vol. 10, Núm. 7, pp. 583-593
2020
-
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 9, pp. 749-757
2019
2010
-
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation
Circulation, Vol. 122, Núm. 10, pp. 1017-1025
2009
-
Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular
Revista Espanola de Cardiologia, Vol. 62, Núm. 9, pp. 1012-1021
2008
-
Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales
Revista Espanola de Cardiologia, Vol. 61, Núm. 8, pp. 803-816